견관절 치환술 시장 보고서 : 디바이스별, 수술법별, 적응증별, 최종사용자별, 지역별(2026-2034년)

The global shoulder arthroplasty market size reached USD 2.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.68% during 2026-2034. The market is propelled by the increasing incidence of shoulder arthritis, development of better implant materials, expanding indications for shoulder replacement procedures, rising population of geriatrics, and heightened consciousness of invasive surgeries.

SHOULDER ARTHROPLASTY MARKET ANALYSIS:

• Major Market Drivers: The shoulder arthroplasty market is spurred by the rise in the prevalence of shoulder arthritis and degenerative ailments that necessitate surgical treatment. Progress in implant materials and design is improving the longevity esthetic performance, and patients' satisfaction. The aging population mainly in the developed countries is a key factor due to the desire by the elderly to continue with their daily activities. Apart from this, other shoulder arthroplasty market drivers include changes in patients' preference from traditional open surgery to the less invasive procedures, which have relatively less downtimes and hospitalizations.
• Key Market Trends: The key trends include the indications toward the performance of reverse shoulder arthroplasty particularly for patients who present with rotator cuff deficiencies. Newer applications of shoulder replacement are being established by the surgeons to fractured patterns, prior surgical failures, and rheumatoid arthritis, escalating the patient portfolio. In addition, advances in computer assistance and robotics are changing the steps of surgery and patients' prognosis, which may be considered as the further development of individual approach in the treatment of diseases of the musculoskeletal system.
• Geographical Trends: The shoulder arthroplasty market insights indicate theta North America dominates shoulder arthroplasty due to its developed healthcare sector, the high incidence rate of shoulder diseases, and active use of surgeries. There is a developed network of healthcare services focused on orthopedic treatment, a high level of reimbursement for surgeries, and a high ratio of used treatment methods.
• Competitive Landscape: Some of the major market players in the shoulder arthroplasty industry include Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation, Zimmer Biomet, among many others.
• Challenges and Opportunities: The market faces challenges such as high fixed costs for shoulder arthroplasty procedures, and high regulatory standards, especially on medical devices. Nevertheless, there remains vast potential in extending the applicability of shoulder replacement and including more detailed developments in implant design to enhance the durability and thus the benefits of the solution. New technologies and products provide prospects for decreasing the rates of complications and improving the process of post-surgical rehabilitation, which stimulates the continual development of the market amid shifting healthcare requirements, thus creating a favorable shoulder arthroplasty market outlook.

SHOULDER ARTHROPLASTY MARKET TRENDS:

Rising Aging Population and Joint Disorders

Rapid globalization and life expectancy are significant factors that have escalated the demand for shoulder arthroplasty. Moreover, this condition is experienced when people grow older and is characterized by a painful stiffening of the shoulder joint caused by osteoarthritis. For instance, the US Census Bureau predicts that in 2030 all baby boomers will be aged 65 years and above, thus increasing the incidences of musculoskeletal disorders. This demographic trend suggests increased utilization of shoulder arthroplasty procedures as a logical consequence. Furthermore, hospitals and governments are increasingly addressing these issues by focusing on joint replacement surgery and orthopaedic care to manage the rising population, thus stimulating shoulder arthroplasty market share.

Ongoing Technological Advancements

Advancements in implant materials and surgical approaches have transformed shoulder arthroplasty by positively impacting the patient's results and subsequent rehabilitation. According to the National Institutes of Health (NIH), new technologies for the minimally invasive approach are growing at a rate of 15% per year and arthroscopic shoulder surgery is a good example of this category as it takes less time to heal than an open surgery. Modem diagnostic imaging techniques such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans assist in diagnosis and planning by providing increased sharpness in surgery. Along with this, advances in technology in 3D printing make it possible to offer customized implants for the best fit and performance of the same which in turn has escalated the shoulder arthroplasty demand. These enhance the quality of life for patients since the procedures decrease pain and enhance mobility. They are resources that attract research and development (R&D) investment to improve the shoulder arthroplasty market.

Escalating Sport Injuries

Increased incidence of sports activities, resulting in conditions like rotator cuff tears and shoulder dislocations, leads to an enhanced need for shoulder arthroplasty among young populations. For instance, the current research reveals that sports-related injuries are major causes of orthopedic visits; the USA experiences more than 8 million sports injury cases annually. Cyclists are among the personalities who may need the services of a surgeon to reconstruct their shoulders because of injury or repetitive strain that leads to pain or contraction. This shoulder arthroplasty market forecast is resulting in the development and adoption of surgery methodologies relevant especially for the sporting figure, including shoulder resurfacing and new tendon repair methods. With the increasing involvement of people in sports across the world, there is a growing need for orthopedic surgeons to offer surgeries such as shoulder arthroplasty, making it an important aspect of managing sporting activities associated with shoulder injuries.

SHOULDER ARTHROPLASTY MARKET SEGMENTATION:

Breakup by Device:

• Shoulder Arthroplasty Resurfacing Implants
• Shoulder Arthroplasty Trauma Devices
• Shoulder Arthroplasty Platform Systems

Resurfacing implants offer an array of procedures of less invasive methods, shortening the recovery period to improve the overall results. Trauma devices are important for procedures concerning cases such as fractures and dislocations which pose challenges when treating and need to be well stabilized. Platform systems enhance top-notch materials and flexibility in operations, which are amendable and offer high accuracy for the long term. These innovations help to drive the market, and this is because the demand for better orthopedic solutions is on the rise globally. They also play a part in increasing the development of treatments in the operation room and in the rehabilitation, therefore benefiting general patient care and quality of life. In the context where healthcare providers and then patients consider new and efficient treatments as a top priority, these technologies remain instrumental in the advancement of shoulder arthroplasty in the international context.

Breakup by Procedure:

• Partial Shoulder Arthroplasty
• Total Shoulder Arthroplasty
• Revision Shoulder Arthroplasty

Revision shoulder arthroplasty holds the largest share of the industry

Revision shoulder arthroplasty holds a relatively large shoulder arthroplasty market share as it is a procedure performed in case of complications or failures of the previous intervention. The U. S. National Institutes of Health (NIH) indicates that revision procedures contribute to roughly 20 % of total shoulder arthroplasty surgeries undertaken annually. This is a result of the rising number of primary total joint arthroplasty procedures and subsequent revision surgeries arising from implant complications, infections, as well as patients' anatomy. The revision processes require intricate methods and individualized instrumentation that help patients regain functionality and experience a reduction in pain, thus promoting the need for better orthopedic services. This quirk is more beneficial for patients with complex cases, and hence the input of surgical specialists that focus on revision arthroplasty is constructive to the market. Consequently, as healthcare facilities focus on outcomes and quality of life, revision shoulder arthroplasty remains an important and growing aspect of orthopedic surgery internationally.

Breakup by Indication:

• Arthritis
• Fracture/Dislocation
• Rotator Cuff Tear Arthropathy
• Hill Sachs Defect
• Others

Arthritis is one of the most common diseases leading to shoulder pain and its treatment calls for joint replacement thus increasing the need for shoulder arthroplasty procedures. Injuries involving bone fractures and dislocations in trauma cases require surgery to stabilize and start the healing process, which upsurges orthopedic implants and devices market. Rotator cuff tear arthropathy is related to chronic shoulder instability requires surgical treatment for treatment and restoration of functioning. In shoulder instability cases, Hill-Sachs defects are common; they are characterized by bone deformities which also need specialized implant designs and procedures to avoid recurrent dislocations. Collectively, these indications drive market advancement by fostering technological advancements regarding surgical methods, implant technologies, and rehabilitation processes, catering to patients' various needs and enhancing the outcomes of shoulder arthroplasty worldwide.

Breakup by End User:

• Hospitals
• Orthopedic Centers
• Ambulatory Surgical Centers
• Others

Hospitals exhibit a clear dominance in the market

As per shoulder arthroplasty industry overview, hospitals account for the largest share of the market owing to their broader framework, and medical facilities. According to data from the Centers for Medicare & Medicaid Services (CMS), hospitals account for approximately 65% of the total shoulder arthroplasty procedures performed annually in the United States alone. This position is backed by the increased facility of hospitals in dealing with complicated situations concerning intricate surgeries and subsequent theater care. They provide numerous orthopedic-related services, and some people present themselves for specialized procedures and treatments of chronic diseases such as arthritis, complications of fractures, and rotator cuff tears. Hospitals also enjoy the reality of preexisting structures which means there is a customer base or rather patients who would require the services of the orthopedic hospitals. They also are involved in research and training, which helps to grow and evolve the available shoulder arthroplasty procedures and tools. Thus, this approach integrates the shoulder arthroplasty market and puts the hospitals at the center of translating the need and demand for shoulder arthroplasty products across the globe.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest shoulder arthroplasty market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest regional market for shoulder arthroplasty.

North America holds the largest share of the shoulder arthroplasty market on the back of several factors. The region has strong healthcare facilities, high healthcare expenditure, and ongoing technological advancements in orthopedic surgeries. According to data from the Centers for Medicare & Medicaid Services (CMS), North America holds approximately 55% of the global shoulder arthroplasty market share. This is further supported by an ageing population susceptible to joint ailments in the region as well as a rise in sportsmen and women with injuries that may only be treated through surgery. Furthermore, the innovation process regarding orthopedic equipment is fueled, primarily, by key players from the industry which has its headquarters mostly in North America and is constantly researching and developing new products for the market. Altogether they make North America a dominating market for shoulder arthroplasty and have immense involvement in determining the overall world market.

COMPETITIVE LANDSCAPE:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the shoulder arthroplasty industry include Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation, and Zimmer Biomet. ()
• The key market players are adopting strategies such as innovation and partnerships to improve their product portfolios and occupancy of the Shoulder Arthroplasty Market. Top orthopedic companies including Zimmer Biomet, DePuy Synthes, and Stryker Corporation are spending on research and development to come up with better implants and certain surgical procedures to ensure patient satisfaction and reduced operational variance. For instance, Smith+Nephew's SMR(R) Shoulder System offers a range of shoulder implants designed to address various pathologies, including anatomical and reverse shoulder arthroplasty options. These companies are also relying on mergers and acquisitions to consolidate their market position and diversify their portfolio of orthopedic applications to respond to the growing need that is brought about by the aging populace and the incidence of sports injuries.

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Shoulder Arthroplasty Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Device

• 6.1 Shoulder Arthroplasty Resurfacing Implants
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Shoulder Arthroplasty Trauma Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Shoulder Arthroplasty Platform Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Procedure

• 7.1 Partial Shoulder Arthroplasty
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Total Shoulder Arthroplasty
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Revision Shoulder Arthroplasty
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Indication

• 8.1 Arthritis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Fracture/Dislocation
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Rotator Cuff Tear Arthropathy
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Hill Sachs Defect
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Orthopedic Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Ambulatory Surgical Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Arthrex Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 SWOT Analysis
  • 15.3.2 BioTek Instruments Inc. (Agilent Technologies Inc.)
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Conmed Corporation
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 DJO Global (Colfax Corporation)
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Exactech Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Implantcast GmbH
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Integra LifeSciences Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Johnson & Johnson
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Kinamed Incorporated
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Limacorporate S.p.A.
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Medacta Group
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
  • 15.3.12 Smith and Nephew Plc
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis
  • 15.3.13 Stryker Corporation
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio
    • 15.3.13.3 Financials
    • 15.3.13.4 SWOT Analysis
  • 15.3.14 Zimmer Biomet
    • 15.3.14.1 Company Overview
    • 15.3.14.2 Product Portfolio
    • 15.3.14.3 Financials
    • 15.3.14.4 SWOT Analysis